These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 19556152

  • 1. Long-term outcome of salvage high-dose chemotherapy in patients with germ cell tumor with poor prognostic features.
    De Giorgi U, Rosti G, Salvioni R, Papiani G, Ballardini M, Pizzocaro G, Marangolo M.
    Urol Oncol; 2011; 29(3):284-90. PubMed ID: 19556152
    [Abstract] [Full Text] [Related]

  • 2. Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor?
    Banna GL, De Giorgi U, Ferrari B, Castagna L, Alloisio M, Marangolo M, Rosti G, Santoro A.
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1085-91. PubMed ID: 17084372
    [Abstract] [Full Text] [Related]

  • 3. High-dose chemotherapy followed by hematological support: experience in the treatment of germ cell tumors.
    Pico JL, Fadel E, Ibrahim A, Bourhis JH, Droz JP.
    Bull Cancer; 1995 Oct; 82 Suppl 1():56s-60s. PubMed ID: 7542945
    [Abstract] [Full Text] [Related]

  • 4. Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database.
    Lorch A, Bascoul-Mollevi C, Kramar A, Einhorn L, Necchi A, Massard C, De Giorgi U, Fléchon A, Margolin K, Lotz JP, Germà-Lluch JR, Powles T, Kollmannsberger C, Beyer J.
    J Clin Oncol; 2011 Jun 01; 29(16):2178-84. PubMed ID: 21444870
    [Abstract] [Full Text] [Related]

  • 5. Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study Group.
    Lorch A, Kollmannsberger C, Hartmann JT, Metzner B, Schmidt-Wolf IG, Berdel WE, Weissinger F, Schleicher J, Egerer G, Haas A, Schirren R, Beyer J, Bokemeyer C, Rick O, German Testicular Cancer Study Group.
    J Clin Oncol; 2007 Jul 01; 25(19):2778-84. PubMed ID: 17602082
    [Abstract] [Full Text] [Related]

  • 6. Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trial.
    Lorch A, Kleinhans A, Kramar A, Kollmannsberger CK, Hartmann JT, Bokemeyer C, Rick O, Beyer J.
    J Clin Oncol; 2012 Mar 10; 30(8):800-5. PubMed ID: 22291076
    [Abstract] [Full Text] [Related]

  • 7. Long-term survival after high-dose salvage chemotherapy for germ cell malignancies with adverse prognostic variables.
    Vaena DA, Abonour R, Einhorn LH.
    J Clin Oncol; 2003 Nov 15; 21(22):4100-4. PubMed ID: 14615439
    [Abstract] [Full Text] [Related]

  • 8. Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy.
    Sammler C, Beyer J, Bokemeyer C, Hartmann JT, Rick O.
    Eur J Cancer; 2008 Jan 15; 44(2):237-43. PubMed ID: 18055194
    [Abstract] [Full Text] [Related]

  • 9. Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors.
    Motzer RJ, Nichols CJ, Margolin KA, Bacik J, Richardson PG, Vogelzang NJ, Bajorin DF, Lara PN, Einhorn L, Mazumdar M, Bosl GJ.
    J Clin Oncol; 2007 Jan 20; 25(3):247-56. PubMed ID: 17235042
    [Abstract] [Full Text] [Related]

  • 10. Long-term survival of patients with recurrent or refractory germ cell tumors after high dose chemotherapy.
    Beyer J, Kingreen D, Krause M, Schleicher J, Schwaner I, Schwella N, Huhn D, Siegert W.
    Cancer; 1997 Jan 01; 79(1):161-8. PubMed ID: 8988741
    [Abstract] [Full Text] [Related]

  • 11. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May 01; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 12. Paclitaxel plus Ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors.
    Kondagunta GV, Bacik J, Sheinfeld J, Bajorin D, Bains M, Reich L, Deluca J, Budnick A, Ishill N, Mazumdar M, Bosl GJ, Motzer RJ.
    J Clin Oncol; 2007 Jan 01; 25(1):85-90. PubMed ID: 17194908
    [Abstract] [Full Text] [Related]

  • 13. The status of high-dose chemotherapy with hematopoietic stem cell transplantation in germ cell tumor patients.
    De Giorgi U, Rosti G, Papiani G, Marangolo M.
    Haematologica; 2002 Jan 01; 87(1):95-104. PubMed ID: 11801470
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors.
    Einhorn LH, Williams SD, Chamness A, Brames MJ, Perkins SM, Abonour R.
    N Engl J Med; 2007 Jul 26; 357(4):340-8. PubMed ID: 17652649
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.